As Russia’s invasion of Ukraine nears its fourth year, more Ukrainian women are joining the war effort — thanks to modern ...
ISLAMABAD: Turkiye has drawn up a plan to establish an assembly facility for its combat drones in Pakistan, with negotiations ...
The very tool that was meant to threaten a sexual assault survivor into silence became one of the most crucial evidence in ...
If Europe wants to excel at tech and innovation, it needs to stop throttling the marketplace with regulations and taxes. Nor ...
By maintaining stability and innovating to hold out against Russia, Kyiv has shown that size matters less in conflict than it ...
Fed Vice Chair Bowman confirms crypto debanking was real. Now banks have permission to serve crypto—but most lack the systems ...
Legendary inventor Lonnie Johnson, 76, believes his Johnson Thermo-Electrochemical Converter could be his most significant ...
Investing in Halozyme Therapeutics is a compelling way to gain exposure to the broader healthcare and biotechnology ...
Ultra-processed foods are entrenched in Singaporeans' busy routines and the country's import-reliant food ecosystem. But as ...
Singapore's heartlands are seeing an influx of young entrepreneurs and chain outlets opening up, replacing decades-old ...
Here are top AI stocks to target in 2026.
Genmab A/S(Nasdaq:GMAB)today announced updated results from two ongoing clinical trials evaluating the efficacy and safety of epcoritamab-bysp, a T-cellengaging antibody administered subcutaneously, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results